SCHEMBL26548758

SCHEMBL26548758

COc1nccc(NC(C)N)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 2/20 0.37
▸ ROCK1 Q13464 1/20 0.36
▸ NOS3 P29474 1/20 0.34
▸ NOS1 P29475 1/20 0.34
▸ NOS2 P35228 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ EGFR P00533 2/20 0.34
▸ PDPK1 O15530 1/20 0.34
▸ LYN P07948 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ BTK Q06187 1/20 0.33
▸ CCR4 P51679 1/20 0.33
▸ MAPK8 P45983 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26573670 0.86 FLT3 (0.39) MAP4K1ROCK1ALDH1A1MEN1NPC1
SCHEMBL16244502 0.78 ROCK1 (0.40) MAP4K1ROCK1NOS3NOS1NOS2
SCHEMBL26536562 0.76 MAP4K1 (0.32) MAP4K1ROCK1ALDH1A1MEN1NPC1
SCHEMBL1154553 0.76 CYP1A2 (0.51) ROCK1NOS3NOS1NOS2ALDH1A1
SCHEMBL21017395 0.73 ALDH1A1 (0.37) MAP4K1ROCK1NOS3NOS1NOS2
SCHEMBL26551523 0.71 TLR8 (0.44) ALDH1A1MEN1LMNAMAPK1KMT2A
SCHEMBL29416507 0.71 PTGDR (0.44) ALDH1A1LYNSRCBTKMAPK8
SCHEMBL30353144 0.70 LYN (0.39) MAP4K1ROCK1ALDH1A1MEN1NPC1
SCHEMBL19116538 0.69 SMN1; SMN2 (0.59) ALDH1A1MEN1NPC1LMNAMAPT
SCHEMBL13950483 0.69 RAB9A (0.59) ROCK1ALDH1A1MEN1NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 — — WO disclosed
Send feedback